[go: up one dir, main page]

AU2793197A - 1,4-disubstituted piperidine derivatives - Google Patents

1,4-disubstituted piperidine derivatives

Info

Publication number
AU2793197A
AU2793197A AU27931/97A AU2793197A AU2793197A AU 2793197 A AU2793197 A AU 2793197A AU 27931/97 A AU27931/97 A AU 27931/97A AU 2793197 A AU2793197 A AU 2793197A AU 2793197 A AU2793197 A AU 2793197A
Authority
AU
Australia
Prior art keywords
piperidine derivatives
disubstituted piperidine
disubstituted
derivatives
piperidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU27931/97A
Inventor
Kumiko Kawakami
Masaru Nishikibe
Takashi Nomoto
Hirokazu Ohsawa
Kenji Ohwaki
Yoshimi Tsuchiya
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MSD KK
Original Assignee
Banyu Phamaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Banyu Phamaceutical Co Ltd filed Critical Banyu Phamaceutical Co Ltd
Publication of AU2793197A publication Critical patent/AU2793197A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU27931/97A 1996-05-31 1997-05-27 1,4-disubstituted piperidine derivatives Abandoned AU2793197A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP8-159176 1996-05-31
JP15917696 1996-05-31
PCT/JP1997/001770 WO1997045414A1 (en) 1996-05-31 1997-05-27 1,4-disubstituted piperidine derivatives

Publications (1)

Publication Number Publication Date
AU2793197A true AU2793197A (en) 1998-01-05

Family

ID=15687966

Family Applications (1)

Application Number Title Priority Date Filing Date
AU27931/97A Abandoned AU2793197A (en) 1996-05-31 1997-05-27 1,4-disubstituted piperidine derivatives

Country Status (2)

Country Link
AU (1) AU2793197A (en)
WO (1) WO1997045414A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2816940A1 (en) * 2000-11-23 2002-05-24 Lipha New 4-(biphenyl carbonylamino) piperidine derivatives are microsomal triglyceride transfer protein and apoprotein B secretion inhibitors used for treating e.g. hypercholesterolemia and obesity
MXPA05000434A (en) 2002-07-08 2005-04-19 Ranbaxy Lab Ltd 3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists.
HK1079787A1 (en) 2002-07-31 2006-04-13 Ranbaxy Laboratories Limited 3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists
WO2004014363A1 (en) 2002-08-09 2004-02-19 Ranbaxy Laboratories Limited 3,6-disubstituted azabicyclo [3.1.0] hexane derivatives useful as muscarinic receptor antagonist
EP1534675B1 (en) 2002-08-23 2009-02-25 Ranbaxy Laboratories, Ltd. Fluoro and sulphonylamino containing 3,6-disubstituted azabicyclo¬3.1.0 hexane derivatives as muscarinic receptor antagonists
WO2004052857A1 (en) * 2002-12-10 2004-06-24 Ranbaxy Laboratories Limited 3,6-disubstituted azabicyclo [3.1.0] hexane derivatives as muscarinic receptor antagonists
AU2002347553A1 (en) 2002-12-23 2004-07-14 Ranbaxy Laboratories Limited Flavaxate derivatives as muscarinic receptor antagonists
EP1583741A1 (en) 2002-12-23 2005-10-12 Ranbaxy Laboratories, Limited 1-substituted-3-pyrrolidine derivatives as muscarinic receptor antagonists
US7488748B2 (en) 2003-01-28 2009-02-10 Ranbaxy Laboratories Limited 3,6-Disubstituted azabicyclo hexane derivatives as muscarinic receptor antagonists
US7517905B2 (en) 2003-04-09 2009-04-14 Ranbaxy Laboratories Limited Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists
AU2003223010A1 (en) 2003-04-10 2004-11-01 Ranbaxy Laboratories Limited Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists
CN100406009C (en) 2003-04-10 2008-07-30 兰贝克赛实验室有限公司 Substituted azabicyclohexane derivatives as muscarinic receptor antagonists
EP1626957A1 (en) 2003-04-11 2006-02-22 Ranbaxy Laboratories Limited Azabicyclo derivatives as muscarinic receptor antagonists
WO2007045979A1 (en) 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Pharmaceutical compositions of muscarinic receptor antagonists

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1231238B (en) * 1987-09-21 1991-11-26 Angeli Inst Spa AMIDIDIC DERIVATIVES
US5750540A (en) * 1995-04-28 1998-05-12 Banyu Pharmaceutical Co., Ltd. 1,4-di-substituted piperidine derivatives

Also Published As

Publication number Publication date
WO1997045414A1 (en) 1997-12-04

Similar Documents

Publication Publication Date Title
HUP9902381A3 (en) Fluorinated 1,4-disubstituted piperidine derivatives
IL127566A0 (en) Substituted 6,5-hetero- bicyclic derivatives
ZA977652B (en) Substituted 6,6-hetero-bicyclic derivatives
AU3356397A (en) Substituted pyrido- or pyrimido-containing 6,6- or 6,7-bicyclic derivatives
AU4073997A (en) 1,4-heterocyclic metallprotease inhibitors
AU2875697A (en) 4-hydroxy-piperidine derivatives
IL145681A0 (en) Substituted 1,2,3,4-tetrahydronaphthalene derivatives
AU2212595A (en) New 1,4-disubstituted piperidine derivatives useful as medicaments acting on the glutamate receptor
AU2894297A (en) 2,4-diaminopyrimidine derivatives
ZA971735B (en) Novel esters of 1,4-disubstituted piperidine derivatives
AU2793197A (en) 1,4-disubstituted piperidine derivatives
AU9256498A (en) 1,4-disubstituted piperazines
AU1636297A (en) Novel 2,3-benzodiazepine derivatives
ZA979781B (en) Piperidine derivatives.
AU4684197A (en) 4-hydroxy-piperidine derivatives
AU7449998A (en) 2,3-dihydrobenzofuran derivatives
AU2158197A (en) Piperidine derivatives
AU1513597A (en) 1,25-dihydroxy-16,22,23-trisdehydro-cholecalciferol derivatives
AU1014697A (en) Piperidine or tetrahydropyridine derivatives
AU5679398A (en) Piperidine derivatives
ZA971357B (en) 1,4-dihydropyridine compounds
AU9462098A (en) Piperidine derivatives
AU6086998A (en) Process for preparing 1,4-disubstituted piperidine compounds
AU3006797A (en) Substituted 1, 3-benzodioxoles
ZA976813B (en) Fluorinep-containing 1,4-disubstituted piperidine derivatives.